7 followers
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.
John Evans
BridgeBio
2 followers
Adaptimmune
2 followers
Thermo Fisher Scientific
166 followers
Genentech
150 followers
Neuralink
60 followers
Cytokinetics
11 followers
Charles River Laboratories
11 followers
Cytiva
10 followers
Ultragenyx Pharmaceutical
10 followers
CRISPR Therapeutics
10 followers
United Therapeutics
7 followers
Explore companies